GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SkinBioTherapeutics PLC (LSE:SBTX) » Definitions » Buildings And Improvements

SkinBioTherapeutics (LSE:SBTX) Buildings And Improvements : £0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is SkinBioTherapeutics Buildings And Improvements?


SkinBioTherapeutics Buildings And Improvements Historical Data

The historical data trend for SkinBioTherapeutics's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SkinBioTherapeutics Buildings And Improvements Chart

SkinBioTherapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Buildings And Improvements
Get a 7-Day Free Trial - - - - -

SkinBioTherapeutics Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SkinBioTherapeutics Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


SkinBioTherapeutics (LSE:SBTX) Business Description

Traded in Other Exchanges
N/A
Address
Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.

SkinBioTherapeutics (LSE:SBTX) Headlines

From GuruFocus

Silverback Therapeutics and ARS Pharmaceuticals Announce Merger

By Business Wire Business Wire 07-21-2022

ARS Pharmaceuticals Closes Merger with Silverback Therapeutics

By Value_Insider Value_Insider 11-08-2022